pureosbio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php crawl-delay:
Meta Tags
Title Home - Pureos
Description Venture capital for companies developing innovative Venture capital for companies developing innovative
Keywords N/A
Server Information
WebSite pureosbio faviconpureosbio.com
Host IP 217.26.51.212
Location Switzerland
Related Websites
Site Rank
More to Explore
pureosbio.com Valuation
US$1,406,704
Last updated: 2023-05-09 10:34:07

pureosbio.com has Semrush global rank of 7,524,191. pureosbio.com has an estimated worth of US$ 1,406,704, based on its estimated Ads revenue. pureosbio.com receives approximately 162,312 unique visitors each day. Its web server is located in Switzerland, with IP address 217.26.51.212. According to SiteAdvisor, pureosbio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,406,704
Daily Ads Revenue US$1,299
Monthly Ads Revenue US$38,955
Yearly Ads Revenue US$467,459
Daily Unique Visitors 10,821
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
pureosbio.com. A 298 IP: 217.26.51.212
pureosbio.com. AAAA 298 IPV6: 2a00:d70:0:b:2002:0:d91a:33d4
pureosbio.com. NS 3600 NS Record: ns2.hostpoint.ch.
pureosbio.com. NS 3600 NS Record: ns3.hostpoint.ch.
pureosbio.com. NS 3600 NS Record: ns.hostpoint.ch.
pureosbio.com. MX 3600 MX Record: 10 pureosbio-com.mail.protection.outlook.com.
pureosbio.com. TXT 3600 TXT Record: MS=ms68930785
pureosbio.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-09 10:34:07
Client Login Portfolio Team News Join us Contact Latest News Alentis Therapeutics announces USD 105 Million USD Series C News: Mehr erfahren Venture capital for companies developing innovative therapeutics Strategy Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. We strive to impact patients’ lives by advancing innovative treatments for severe diseases. Portfolio Our companies are developing innovative therapeutics for severe diseases and conditions. We are backing great teams with development programs that make a true difference for patients. Acrivon Therapeutics Acrivon Therapeutics is a clinical stage oncology company developing novel cancer drugs paired with companion diagnostics predicting treatment response and driving patient selection. In November 2022, Acrivon went public at the NASDAQ (ACRV). acrivon.com Alentis Therapeutics AlentisTherapeutics discovers
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 31 Oct 2021 17:45:08 GMT
Server: Apache
Location: https://pureosbio.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 301 
x-redirect-by: WordPress
location: https://www.pureosbio.com/
content-type: text/html; charset=UTF-8
date: Sun, 31 Oct 2021 17:45:08 GMT
server: Apache

HTTP/2 200 
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
vary: Accept-Encoding
content-type: text/html; charset=UTF-8
date: Sun, 31 Oct 2021 17:45:09 GMT
server: Apache
pureosbio.com Whois Information
Domain Name: PUREOSBIO.COM
Registry Domain ID: 2117522433_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2021-04-26T07:05:48Z
Creation Date: 2017-04-25T07:27:01Z
Registry Expiry Date: 2022-04-25T07:27:01Z
Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Registrar IANA ID: 106
Registrar Abuse Contact Email: abuse@ascio.com
Registrar Abuse Contact Phone: +1.4165350123
Domain Status: ok https://icann.org/epp#ok
Name Server: NS.HOSTPOINT.CH
Name Server: NS2.HOSTPOINT.CH
Name Server: NS3.HOSTPOINT.CH
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-19T03:28:03Z <<<

Copyright © 2022 WebZZ.US 0.0273